Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Res Vet Sci ; 93(2): 975-82, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22284769

ABSTRACT

The objective of this study was to investigate intestinal function and morphology associated with peri-weaning failure to thrive syndrome (PFTS) in swine. Jejunum and distal ileum from control and pigs exhibiting PFTS was harvested at weaning, 4 and 11 days post-weaning (PW) for intestinal barrier function studies and histological analyses (n=6 pigs per group). Marked disturbances in intestinal barrier function was observed in PFTS pigs, compared with controls, indicated by lower (p<0.05) TER and increased (p<0.01) permeability to FITC dextran (4 kDa). Intestines from weaned pigs, subjected to a 4-day fast, exhibited minor disturbances in intestinal barrier function. Villus atrophy and crypt hyperplasia were observed in the PFTS intestine compared with control and fasted pigs. These data demonstrate that PFTS is associated with profound disturbances in intestinal epithelial barrier function and alterations in mucosal and epithelial morphology in which anorexia is not the sole factor.


Subject(s)
Failure to Thrive/veterinary , Intestinal Mucosa/pathology , Intestine, Small/pathology , Swine Diseases/pathology , Animals , Dextrans , Failure to Thrive/pathology , Female , Fluorescein-5-isothiocyanate/analogs & derivatives , Swine , Weaning
2.
Am J Physiol Gastrointest Liver Physiol ; 298(3): G352-63, 2010 Mar.
Article in English | MEDLINE | ID: mdl-19926814

ABSTRACT

Early life stress is a predisposing factor for the development of chronic intestinal disorders in adult life. Here, we show that stress associated with early weaning in pigs leads to impaired mucosal barrier function. Early weaning (15- to 21-day weaning age) resulted in sustained impairment in intestinal barrier function, as indicated by reductions in jejunal transepithelial electrical resistance and elevations in mucosal-to-serosal flux of paracellular probes [(3)H]mannitol and [(14)C]inulin measured at 5 and 9 wk of age, compared with that shown in late-weaned pigs (23- to 28-day weaning age). Elevated baseline short-circuit current was observed in jejunum from early-weaned pigs and was shown to be mediated via enhanced Cl(-) secretion. Jejunal barrier dysfunction in early-weaned pigs coincided with increased lamina propria immune cell density particularly mucosal mast cells. The mast cell stabilizer drug sodium cromoglycolate ameliorated barrier dysfunction and hypersecretion in early-weaned pigs, demonstrating an important role of mast cells. Furthermore, activation of mast cells ex vivo with c48/80 and corticotrophin-releasing factor (CRF) in pig jejunum mounted in Ussing chambers induced barrier dysfunction and elevations in short-circuit current that were inhibited with mast cell protease inhibitors. Experiments in which selective CRF receptor antagonists were administered to early-weaned pigs revealed that CRF receptor 1 (CRFr1) activation mediates barrier dysfunction and hypersecretion, whereas CRFr2 activation may be responsible for novel protective properties in the porcine intestine in response to early life stress.


Subject(s)
Intestinal Mucosa/physiopathology , Stress, Physiological/physiology , Weaning , Animals , Animals, Newborn , Barium Compounds/pharmacology , Cell Count , Chlorides/pharmacology , Corticotropin-Releasing Hormone/blood , Corticotropin-Releasing Hormone/metabolism , Corticotropin-Releasing Hormone/pharmacology , Cromolyn Sodium/pharmacology , Electric Impedance , Electrophysiological Phenomena/drug effects , Electrophysiological Phenomena/physiology , Female , Hydrocortisone/blood , Intestinal Mucosa/drug effects , Intestinal Mucosa/metabolism , Intestinal Mucosa/pathology , Inulin/metabolism , Ion Transport/physiology , Jejunum/drug effects , Jejunum/metabolism , Jejunum/pathology , Jejunum/physiopathology , Male , Mannitol/metabolism , Mast Cells/drug effects , Mast Cells/metabolism , Mast Cells/pathology , Permeability , Potassium/metabolism , Potassium Channel Blockers/pharmacology , Protease Inhibitors/pharmacology , Receptors, Corticotropin-Releasing Hormone/antagonists & inhibitors , Receptors, Corticotropin-Releasing Hormone/metabolism , Receptors, Glucocorticoid/metabolism , Sus scrofa , Tryptases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...